Compounds > pravastatin
Page last updated: 2024-08-23

pravastatin and Esophageal Neoplasms

pravastatin has been researched along with Esophageal Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Chen, M; Chen, WM; Shia, BC; Wu, SY; Yu, YH1
Chen, Y; Li, LB; Tang, DP; Wei, JJ; Zhang, J; Zhuang, ZH1
Fullerton, DA; Meng, X; Reece, TB; Reppert, AE; Sadaria, MR; Weyant, MJ; Yu, JA1
Beales, IL; Ogunwobi, OO1
Hawk, ET; Viner, JL1

Other Studies

5 other study(ies) available for pravastatin and Esophageal Neoplasms

ArticleYear
Statin Use During Concurrent Chemoradiotherapy With Improved Survival Outcomes in Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Nationwide Cohort Study.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2023, Volume: 18, Issue:8

    Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Cohort Studies; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lung Neoplasms; Pravastatin; Propensity Score; Rosuvastatin Calcium

2023
Simvastatin, but not pravastatin, inhibits the proliferation of esophageal adenocarcinoma and squamous cell carcinoma cells: a cell-molecular study.
    Lipids in health and disease, 2018, Dec-22, Volume: 17, Issue:1

    Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Dinoprostone; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation; Humans; Pravastatin; Simvastatin

2018
Statin therapy attenuates growth and malignant potential of human esophageal adenocarcinoma cells.
    The Journal of thoracic and cardiovascular surgery, 2011, Volume: 142, Issue:5

    Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Atorvastatin; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Esophageal Neoplasms; Flow Cytometry; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intercellular Adhesion Molecule-1; NF-kappa B; Pravastatin; Pyrroles; Simvastatin

2011
Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.
    The American journal of gastroenterology, 2008, Volume: 103, Issue:4

    Topics: Adenocarcinoma; Analysis of Variance; Animals; Apoptosis; Barrett Esophagus; Caspase 3; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Esophageal Neoplasms; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoblotting; Lovastatin; Mevalonic Acid; Nitrobenzenes; Polyisoprenyl Phosphates; Pravastatin; Protein Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sesquiterpenes; Signal Transduction; Simvastatin; Sulfonamides

2008
Statins in esophageal cancer cell lines: promising lead?
    The American journal of gastroenterology, 2008, Volume: 103, Issue:4

    Topics: Adenocarcinoma; Animals; Apoptosis; Barrett Esophagus; Cell Line, Tumor; Dose-Response Relationship, Drug; Esophageal Neoplasms; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Pravastatin; Simvastatin

2008